Literature DB >> 22189068

Effect studies of human pharmaceuticals on Fucus vesiculosus and Gammarus spp.

Hanna Oskarsson1, Ann-Kristin Eriksson Wiklund, Karolina Lindh, Linda Kumblad.   

Abstract

In two experiments, the human pharmaceutical propranolol negatively affected the physiology of two test organisms, Fucus vesiculosus and Gammarus spp. from a Baltic Sea littoral community in a concentration of 1000 μg l⁻¹. Some effects were also observed for the lower, more ecologically relevant concentrations (10 μg l⁻¹ and 100 μg l⁻¹). The effects on F. vesiculosus not only increased with increasing concentration, but also with exposure time; while the effects on Gammarus spp. were more inconsistent over time. No clear effects of the pharmaceuticals diclofenac and ibuprofen were observed for any of the organisms. Physiological parameters measured were GP:R-ratio, chlorophyll fluorescence and release of coloured dissolved organic matter, respiration and ammonium excretion. Pharmaceutical substances are repeatedly detected in the Baltic Sea which is the recipient for STP effluents from more than 85 million people living in the catchment area, but the knowledge of their effects on non-target organisms is still very limited.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22189068     DOI: 10.1016/j.marenvres.2011.11.001

Source DB:  PubMed          Journal:  Mar Environ Res        ISSN: 0141-1136            Impact factor:   3.130


  2 in total

1.  Effects of pharmaceuticals and personal care products on marine organisms: from single-species studies to an ecosystem-based approach.

Authors:  Emma Prichard; Elise F Granek
Journal:  Environ Sci Pollut Res Int       Date:  2016-09-12       Impact factor: 4.223

2.  Community interactions modify the effects of pharmaceutical exposure: a microcosm study on responses to propranolol in Baltic Sea coastal organisms.

Authors:  Hanna Oskarsson; Ann-Kristin Eriksson Wiklund; Gunnar Thorsén; Gabriela Danielsson; Linda Kumblad
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.